Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features

Neuroscience and Biobehavioral Reviews

Volumn 67, Issue , 2016, Pages 25-40

  Melcangi, Roberto C ^a   Giatti, Silvia ^a   Garcia Segura, Luis M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTO CAJAL   (Spain)

Author keywords

5alpha Reductase; Aromatase; Dihydroprogesterone; Dihydrotestosterone; Estradiol; Pregnenolone; Progesterone; Testosterone; Tetrahydroprogesterone

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; ANDROGEN; ANDROSTANOLONE; ESTRADIOL; NEUROACTIVE STEROID; PRASTERONE; PROGESTERONE; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ALZHEIMER DISEASE; ANXIETY; AUTISM; BRAIN DISEASE; CEREBROVASCULAR ACCIDENT; DEPRESSION; DIABETIC NEUROPATHY; GENDER; GENE EXPRESSION; HORMONAL THERAPY; HORMONE ACTION; HORMONE METABOLISM; HUMAN; HUNTINGTON CHOREA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SPINAL CORD INJURY; STEROIDOGENESIS; TRAUMATIC BRAIN INJURY; FEMALE; MALE; SEXUAL DEVELOPMENT;

FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; NEUROTRANSMITTER AGENTS; SEX CHARACTERISTICS; STEROIDS;

EID: 84954290505     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.09.023     Document Type: Review

References (356)

1. Aaberg, M.L., Burch, D.M., Hud, Z.R., Zacharias, M.P., Gender differences in the onset of diabetic neuropathy. J. Diabetes Complications 22 (2008), 83–87.
2. Acs, P., Kipp, M., Norkute, A., Johann, S., Clarner, T., Braun, A., Berente, Z., Komoly, S., Beyer, C., 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57 (2009), 807–814.
3. Afifi, M., Gender differences in mental health. Singapore Med. J. 48 (2007), 385–391.
4. Albers, J.W., Brown, M.B., Sima, A.A., Greene, D.A., Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 46 (1996), 85–91.
5. Alkayed, N.J., Harukuni, I., Kimes, A.S., London, E.D., Traystman, R.J., Hurn, P.D., Gender-linked brain injury in experimental stroke. Stroke 29 (1998), 159–165 discussion 166.
6. Ammendola, A., Gemini, D., Iannaccone, S., Argenzio, F., Ciccone, G., Ammendola, E., Serio, L., Ugolini, G., Bravaccio, F., Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol Alcohol. 35 (2000), 368–371.
7. Andersen, K., Launer, L.J., Dewey, M.E., Letenneur, L., Ott, A., Copeland, J.R., Dartigues, J.F., Kragh-Sorensen, P., Baldereschi, M., Brayne, C., Lobo, A., Martinez-Lage, J.M., Stijnen, T., Hofman, A., Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group. Neurology 53 (1999), 1992–1997.
8. Andreasen, N.C., Ehrhardt, J.C., Swayze, V.W. 2nd, Alliger, R.J., Yuh, W.T., Cohen, G., Ziebell, S., Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch. Gen. Psychiatry 47 (1990), 35–44.
9. Andreasen, N.C., Flashman, L., Flaum, M., Arndt, S., Swayze, V. 2nd, O'Leary, D.S., Ehrhardt, J.C., Yuh, W.T., Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 272 (1994), 1763–1769.
10. Arad, M., Weiner, I., Sex-dependent antipsychotic capacity of 17beta-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males. Neuropsychopharmacology 35 (2010), 2179–2192.
11. Ardeshiri, A., Kelley, M.H., Korner, I.P., Hurn, P.D., Herson, P.S., Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen–glucose deprivation. Eur. J. Neurosci. 24 (2006), 2567–2574.
12. Arevalo, M.A., Azcoitia, I., Garcia-Segura, L.M., The neuroprotective actions of oestradiol and oestrogen receptors. Nat. Rev. Neurosci. 16 (2015), 17–29.
13. Arevalo, M.A., Azcoitia, I., Gonzalez-Burgos, I., Garcia-Segura, L.M., Signaling mechanisms mediating the regulation of synaptic plasticity and memory by estradiol. Horm. Behav., 2015, 10.1016/j.yhbeh.2015.04.016.
14. Arevalo, M.A., Ruiz-Palmero, I., Scerbo, M.J., Acaz-Fonseca, E., Cambiasso, M.J., Garcia-Segura, L.M., Molecular mechanisms involved in the regulation of neuritogenesis by estradiol: recent advances. J. Steroid Biochem. Mol. Biol. 131 (2012), 52–56.
15. Arevalo, M.A., Santos-Galindo, M., Acaz-Fonseca, E., Azcoitia, I., Garcia-Segura, L.M., Gonadal hormones and the control of reactive gliosis. Horm. Behav. 63 (2012), 216–221.
16. Ayhan, S., Markal, N., Siemionow, K., Araneo, B., Siemionow, M., Effect of subepineurial dehydroepiandrosterone treatment on healing of transected nerves repaired with the epineurial sleeve technique. Microsurgery 23 (2003), 49–55.
17. Ayoola, C., Hwang, S.M., Hong, S.J., Rose, K.E., Boyd, C., Bozic, N., Park, J.Y., Osuru, H.P., DiGruccio, M.R., Covey, D.F., Jevtovic-Todorovic, V., Todorovic, S.M., Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. Psychopharmacology (Berl.) 231 (2014), 3503–3515.
18. Azcoitia, I., Leonelli, E., Magnaghi, V., Veiga, S., Garcia-Segura, L.M., Melcangi, R.C., Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 24 (2003), 853–860.
19. Azcoitia, I., Sierra, A., Garcia-Segura, L.M., Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J. Neurosci. Res. 58 (1999), 815–822.
20. Azcoitia, I., Sierra, A., Veiga, S., Honda, S., Harada, N., Garcia-Segura, L.M., Brain aromatase is neuroprotective. J. Neurobiol. 47 (2001), 318–329.
21. Backstrom, T., Bixo, M., Johansson, M., Nyberg, S., Ossewaarde, L., Ragagnin, G., Savic, I., Stromberg, J., Timby, E., van Broekhoven, F., van Wingen, G., Allopregnanolone and mood disorders. Prog. Neurobiol. 113 (2014), 88–94.
22. Barfield, R.J., Glaser, J.H., Rubin, B.S., Etgen, A.M., Behavioral effects of progestin in the brain. Psychoneuroendocrinology 9 (1984), 217–231.
23. Barraclough, C.A., Camp, P., Weiland, N., Akabori, A., Stimulatory versus inhibitory effects of progesterone on estrogen-induced phasic LH and prolactin secretion correlated with estrogen nuclear and progestin cytosol receptor concentrations in brain and pituitary gland. Neuroendocrinology 42 (1986), 6–14.
24. Barreto, G., Santos-Galindo, M., Diz-Chaves, Y., Pernia, O., Carrero, P., Azcoitia, I., Garcia-Segura, L.M., Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones. Endocrinology 150 (2009), 5010–5015.
25. Barreto, G., Veiga, S., Azcoitia, I., Garcia-Segura, L.M., Garcia-Ovejero, D., Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 25 (2007), 3039–3046.
26. Barreto, G.E., Santos-Galindo, M., Garcia-Segura, L.M., Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury. Front. Aging Neurosci., 6, 2014, 132.
27. Basit, A., Hydrie, M.Z., Hakeem, R., Ahmedani, M.Y., Masood, Q., Frequency of chronic complications of type II diabetes. J. Coll. Physicians Surg. Pak. 14 (2004), 79–83.
28. Baudry, M., Bi, X., Aguirre, C., Progesterone–estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience 239 (2013), 280–294.
29. Bauman, M.L., Kemper, T.L., Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23 (2005), 183–187.
30. Bebo, B.F. Jr., Adlard, K., Schuster, J.C., Unsicker, L., Vandenbark, A.A., Offner, H., Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. J. Neurosci. Res. 55 (1999), 432–440.
31. Bebo, B.F. Jr., Schuster, J.C., Vandenbark, A.A., Offner, H., Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162 (1999), 35–40.
32. Beinhoff, U., Tumani, H., Brettschneider, J., Bittner, D., Riepe, M.W., Gender-specificities in Alzheimer's disease and mild cognitive impairment. J. Neurol. 255 (2008), 117–122.
33. Bender, R.A., Zhou, L., Wilkars, W., Fester, L., Lanowski, J.S., Paysen, D., Konig, A., Rune, G.M., Roles of 17ss-estradiol involve regulation of reelin expression and synaptogenesis in the dentate gyrus. Cereb. Cortex 20 (2010), 2985–2995.
34. Benito-Leon, J., Bermejo-Pareja, F., Rodriguez, J., Molina, J.A., Gabriel, R., Morales, J.M., Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov. Disord. 18 (2003), 267–274.
35. Biamonte, F., Assenza, G., Marino, R., D'Amelio, M., Panteri, R., Caruso, D., Scurati, S., Yague, J.G., Garcia-Segura, L.M., Cesa, R., Strata, P., Melcangi, R.C., Keller, F., Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival. Neurobiol. Dis. 36 (2009), 103–115.
36. Biessels, G.J., Deary, I.J., Ryan, C.M., Cognition and diabetes: a lifespan perspective. Lancet Neurol. 7 (2008), 184–190.
37. Biessels, G.J., van der Heide, L.P., Kamal, A., Bleys, R.L., Gispen, W.H., Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 441 (2002), 1–14.
38. Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., Bayer, T.A., Langui, D., Duyckaerts, C., Tremp, G., Pradier, L., Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 184 (2003), 247–263.
39. Bloch, Y., Ratzoni, G., Sobol, D., Mendlovic, S., Gal, G., Levkovitz, Y., Gender differences in electroconvulsive therapy: a retrospective chart review. J. Affect. Disord. 84 (2005), 99–102.
40. Bode, F.J., Stephan, M., Suhling, H., Pabst, R., Straub, R.H., Raber, K.A., Bonin, M., Nguyen, H.P., Riess, O., Bauer, A., Sjoberg, C., Petersen, A., von Horsten, S., Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum. Mol. Genet. 17 (2008), 2595–2609.
41. Booya, F., Bandarian, F., Larijani, B., Pajouhi, M., Nooraei, M., Lotfi, J., Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol., 5, 2005, 24.
42. Bourque, M., Dluzen, D.E., Di Paolo, T., Neuroprotective actions of sex steroids in Parkinson's disease. Front. Neuroendocrinol. 30 (2009), 142–157.
43. Bowers, J.M., Waddell, J., McCarthy, M.M., A developmental sex difference in hippocampal neurogenesis is mediated by endogenous oestradiol. Biol. Sex Differ., 1, 2010, 8.
44. Bryant, N.L., Buchanan, R.W., Vladar, K., Breier, A., Rothman, M., Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. Am. J. Psychiatry 156 (1999), 603–609.
45. Calabrese, D., Giatti, S., Romano, S., Porretta-Serapiglia, C., Bianchi, R., Milanese, M., Bonanno, G., Caruso, D., Viviani, B., Gardoni, F., Garcia-Segura, L.M., Melcangi, R.C., Diabetic neuropathic pain: a role for testosterone metabolites. J. Endocrinol. 221 (2014), 1–13.
46. Callahan, M.J., Lipinski, W.J., Bian, F., Durham, R.A., Pack, A., Walker, L.C., Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am. J. Pathol. 158 (2001), 1173–1177.
47. Callier, S., Morissette, M., Grandbois, M., Pelaprat, D., Di Paolo, T., Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse 41 (2001), 131–138.
48. Calmarza-Font, I., Lagunas, N., Garcia-Segura, L.M., Antidepressive and anxiolytic activity of selective estrogen receptor modulators in ovariectomized mice submitted to chronic unpredictable stress. Behav. Brain Res. 227 (2012), 287–290.
49. Caruso, D., Barron, A.M., Brown, M.A., Abbiati, F., Carrero, P., Pike, C.J., Garcia-Segura, L.M., Melcangi, R.C., Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiol. Aging 34 (2013), 1080–1089.
50. Caruso, D., D'Intino, G., Giatti, S., Maschi, O., Pesaresi, M., Calabrese, D., Garcia-Segura, L.M., Calza, L., Melcangi, R.C., Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. J. Neurochem. 114 (2010), 921–932.
51. Caruso, D., Melis, M., Fenu, G., Giatti, S., Romano, S., Grimoldi, M., Crippa, D., Marrosu, M.G., Cavaletti, G., Melcangi, R.C., Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients. J. Neurochem. 130 (2014), 591–597.
52. Caruso, D., Pesaresi, M., Abbiati, F., Calabrese, D., Giatti, S., Garcia-Segura, L.M., Melcangi, R.C., Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats. Psychoneuroendocrinology 38 (2013), 2278–2290.
53. Caruso, D., Pesaresi, M., Maschi, O., Giatti, S., Garcia-Segura, L.M., Melcangi, R.C., Effects of short- and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats. J. Neuroendocrinol. 22 (2010), 1137–1147.
54. Caruso, D., Scurati, S., Roglio, I., Nobbio, L., Schenone, A., Melcangi, R.C., Neuroactive steroid levels in a transgenic rat model of CMT1A Neuropathy. J. Mol. Neurosci. 34 (2008), 249–253.
55. Celec, P., Ostatnikova, D., Hodosy, J., On the effects of testosterone on brain behavioral functions. Front. Neurosci., 9, 2015, 12.
56. Cermenati, G., Abbiati, F., Cermenati, S., Brioschi, E., Volonterio, A., Cavaletti, G., Saez, E., De Fabiani, E., Crestani, M., Garcia-Segura, L.M., Melcangi, R.C., Caruso, D., Mitro, N., Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J. Lipid Res. 53 (2012), 300–310.
57. Cermenati, G., Brioschi, E., Abbiati, F., Melcangi, R.C., Caruso, D., Mitro, N., Liver X receptors, nervous system, and lipid metabolism. J. Endocrinol. Invest. 36 (2013), 435–443.
58. Chan, J.R., Phillips, L.J. 2nd, Glaser, M., Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 10459–10464.
59. Chan, J.R., Rodriguez-Waitkus, P.M., Ng, B.K., Liang, P., Glaser, M., Progesterone synthesized by Schwann cells during myelin formation regulates neuronal gene expression. Mol. Biol. Cell 11 (2000), 2283–2295.
60. Chavez-Delgado, M.E., Gomez-Pinedo, U., Feria-Velasco, A., Huerta-Viera, M., Castaneda, S.C., Toral, F.A., Parducz, A., Anda, S.L., Mora-Galindo, J., Garcia-Estrada, J., Ultrastructural analysis of guided nerve regeneration using progesterone- and pregnenolone-loaded chitosan prostheses. J. Biomed. Mater Res. B: Appl. Biomater. 74 (2005), 589–600.
61. Chisholm, N.C., Henderson, M.L., Selvamani, A., Park, M.J., Dindot, S., Miranda, R.C., Sohrabji, F., Histone methylation patterns in astrocytes are influenced by age following ischemia. Epigenetics 10 (2015), 142–152.
62. Chisholm, N.C., Sohrabji, F., Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging. Neurobiol. Dis., 2015, 10.1016/j.nbd.2015.03.028.
63. Cho, T., Chaban, V.V., Interaction between P2X3 and oestrogen receptor (ER)alpha/ERbeta in ATP-mediated calcium signalling in mice sensory neurones. J. Neuroendocrinol. 24 (2012), 789–797.
64. Chowen, J.A., Torres-Aleman, I., Garcia-Segura, L.M., Trophic effects of estradiol on fetal rat hypothalamic neurons. Neuroendocrinology 56 (1992), 895–901.
65. Ciriza, I., Azcoitia, I., Garcia-Segura, L.M., Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 16 (2004), 58–63.
66. Ciriza, I., Carrero, P., Azcoitia, I., Lundeen, S.G., Garcia-Segura, L.M., Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J. Neurobiol. 61 (2004), 209–221.
67. Ciriza, I., Carrero, P., Frye, C.A., Garcia-Segura, L.M., Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 66 (2006), 916–928.
68. Clinton, L.K., Billings, L.M., Green, K.N., Caccamo, A., Ngo, J., Oddo, S., McGaugh, J.L., LaFerla, F.M., Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol. Dis. 28 (2007), 76–82.
69. Coers, S., Tanzer, L., Jones, K.J., Testosterone treatment attenuates the effects of facial nerve transection on glial fibrillary acidic protein (GFAP) levels in the hamster facial motor nucleus. Metab. Brain Dis. 17 (2002), 55–63.
70. Coirini, H., Gouezou, M., Liere, P., Delespierre, B., Pianos, A., Eychenne, B., Schumacher, M., Guennoun, R., 3 Beta-hydroxysteroid dehydrogenase expression in rat spinal cord. Neuroscience 113 (2002), 883–891.
71. Colciago, A., Casati, L., Negri-Cesi, P., Celotti, F., Learning and memory: steroids and epigenetics. J. Steroid Biochem. Mol. Biol. 150 (2015), 64–85.
72. Confavreux, C., Vukusic, S., Adeleine, P., Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003), 770–782.
73. Corbo, R.M., Gambina, G., Broggio, E., Scarabino, D., Scacchi, R., Association study of two steroid biosynthesis genes (COMT and CYP17) with Alzheimer's disease in the Italian population. J. Neurol. Sci. 344 (2014), 149–153.
74. Corpechot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J.N., Touyer, G., Mouren, M., Prasad, V.V., Banner, C., Sjovall, J., Baulieu, E.E., Robel, P., Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133 (1993), 1003–1009.
75. Cutler, S.M., Cekic, M., Miller, D.M., Wali, B., VanLandingham, J.W., Stein, D.G., Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 24 (2007), 1475–1486.
76. Czlonkowska, A., Ciesielska, A., Gromadzka, G., Kurkowska-Jastrzebska, I., Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29 (2006), 243–256.
77. D'Arcangelo, G., Miao, G.G., Chen, S.C., Soares, H.D., Morgan, J.I., Curran, T., A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374 (1995), 719–723.
78. Dalal, M., Kim, S., Voskuhl, R.R., Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159 (1997), 3–6.
79. Davis, D.P., Douglas, D.J., Smith, W., Sise, M.J., Vilke, G.M., Holbrook, T.L., Kennedy, F., Eastman, A.B., Velky, T., Hoyt, D.B., Traumatic brain injury outcomes in pre- and post-menopausal females versus age-matched males. J. Neurotrauma 23 (2006), 140–148.
80. Day, N.L., Floyd, C.L., D'Alessandro, T.L., Hubbard, W.J., Chaudry, I.H., 17beta-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1. J. Neurotrauma 30 (2013), 1531–1541.
81. de Lau, L.M., Giesbergen, P.C., de Rijk, M.C., Hofman, A., Koudstaal, P.J., Breteler, M.M., Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63 (2004), 1240–1244.
82. Devroey, D., Van Casteren, V., Buntinx, F., Registration of stroke through the Belgian sentinel network and factors influencing stroke mortality. Cerebrovasc. Dis. 16 (2003), 272–279.
83. di Michele, F., Longone, P., Romeo, E., Lucchetti, S., Brusa, L., Pierantozzi, M., Bassi, A., Bernardi, G., Stanzione, P., Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease. Neurol. Sci. 24 (2003), 172–173.
84. Dina, O.A., Gear, R.W., Messing, R.O., Levine, J.D., Severity of alcohol-induced painful peripheral neuropathy in female rats: role of estrogen and protein kinase (A and Cepsilon). Neuroscience 145 (2007), 350–356.
85. Diz-Chaves, Y., Kwiatkowska-Naqvi, A., Von Hulst, H., Pernia, O., Carrero, P., Garcia-Segura, L.M., Behavioral effects of estradiol therapy in ovariectomized rats depend on the age when the treatment is initiated. Exp. Gerontol. 47 (2012), 93–99.
86. Djebaili, M., Guo, Q., Pettus, E.H., Hoffman, S.W., Stein, D.G., The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 22 (2005), 106–118.
87. Dooley, M.A., Hogan, S.L., Environmental epidemiology and risk factors for autoimmune disease. Curr. Opin. Rheumatol. 15 (2003), 99–103.
88. Dorner, J.L., Miller, B.R., Barton, S.J., Brock, T.J., Rebec, G.V., Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav. Brain Res. 178 (2007), 90–97.
89. Doulazmi, M., Frederic, F., Lemaigre-Dubreuil, Y., Hadj-Sahraoui, N., Delhaye-Bouchaud, N., Mariani, J., Cerebellar Purkinje cell loss during life span of the heterozygous staggerer mouse (Rora(+)/Rora(sg)) is gender-related. J. Comp. Neurol. 411 (1999), 267–273.
90. El-Etr, M., Rame, M., Boucher, C., Ghoumari, A.M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., Sitruk-Ware, R., Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia 63 (2015), 104–117.
91. Elkabes, S., Nicot, A.B., Sex steroids and neuroprotection in spinal cord injury: a review of preclinical investigations. Exp. Neurol. 259 (2014), 28–37.
92. Eriksson, M., Norrving, B., Terent, A., Stegmayr, B., Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc. Dis. 25 (2008), 423–429.
93. Farace, E., Alves, W.M., Do women fare worse: a metaanalysis of gender differences in traumatic brain injury outcome. J. Neurosurg. 93 (2000), 539–545.
94. Fernandez, H.H., Lapane, K.L., Ott, B.R., Friedman, J.H., Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. Mov. Disord. 15 (2000), 490–496.
95. Fex Svenningsen, A., Kanje, M., Estrogen and progesterone stimulate Schwann cell proliferation in a sex- and age-dependent manner. J. Neurosci. Res. 57 (1999), 124–130.
96. Fombonne, E., The epidemiology of autism: a review. Psychol. Med. 29 (1999), 769–786.
97. Fombonne, E., Epidemiological surveys of autism and other pervasive developmental disorders: an update. J. Autism Dev. Disord. 33 (2003), 365–382.
98. Foot, M., Koszycki, D., Gender differences in anxiety-related traits in patients with panic disorder. Depress. Anxiety 20 (2004), 123–130.
99. Foroud, T., Gray, J., Ivashina, J., Conneally, P.M., Differences in duration of Huntington's disease based on age at onset. J. Neurol. Neurosurg. Psychiatry 66 (1999), 52–56.
100. Foy, M.R., Akopian, G., Thompson, R.F., Progesterone regulation of synaptic transmission and plasticity in rodent hippocampus. Learn. Mem. 15 (2008), 820–822.
101. Frankfurt, M., Luine, V., The evolving role of dendritic spines and memory: interaction(s) with estradiol. Horm. Behav., 2015, 10.1016/j.yhbeh.2015.05.004.
102. Fratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., Winblad, B., Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48 (1997), 132–138.
103. Frye, C.A., Koonce, C.J., Edinger, K.L., Osborne, D.M., Walf, A.A., Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm. Behav. 54 (2008), 726–734.
104. Frye, C.A., Ryan, A., Rhodes, M., Antiseizure effects of 3alpha-androstanediol and/or 17beta-estradiol may involve actions at estrogen receptor beta. Epilepsy Behav. 16 (2009), 418–422.
105. Frye, C.A., Scalise, T.J., Anti-seizure effects of progesterone and 3alpha, 5alpha-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25 (2000), 407–420.
106. Galea, L.A., Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res. Rev. 57 (2008), 332–341.
107. Garay, L., Deniselle, M.C., Lima, A., Roig, P., De Nicola, A.F., Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 107 (2007), 228–237.
108. Garay, L., Gonzalez Deniselle, M.C., Gierman, L., Lima, A., Roig, P., De Nicola, A.F., Pharmacotherapy with 17beta-estradiol and progesterone prevents development of mouse experimental autoimmune encephalomyelitis. Horm. Mol. Biol. Clin. Investig. 1 (2010), 43–51.
109. Garay, L., Tungler, V., Deniselle, M.C., Lima, A., Roig, P., De Nicola, A.F., Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience 192 (2011), 588–597.
110. Garcia-Estrada, J., Del Rio, J.A., Luquin, S., Soriano, E., Garcia-Segura, L.M., Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 628 (1993), 271–278.
111. Garcia-Estrada, J., Luquin, S., Fernandez, A.M., Garcia-Segura, L.M., Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci. 17 (1999), 145–151.
112. Garcia-Segura, L.M., Chowen, J.A., Parducz, A., Naftolin, F., Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms. Prog. Neurobiol. 44 (1994), 279–307.
113. Garcia-Segura, L.M., Torres-Aleman, I., Naftolin, F., Astrocytic shape and glial fibrillary acidic protein immunoreactivity are modified by estradiol in primary rat hypothalamic cultures. Brain Res. Dev. Brain Res. 47 (1989), 298–302.
114. Gemignani, F., Brindani, F., Negrotti, A., Vitetta, F., Alfieri, S., Marbini, A., Restless legs syndrome and polyneuropathy. Mov. Disord. 21 (2006), 1254–1257.
115. Ghorbanpoor, S., Garcia-Segura, L.M., Haeri-Rohani, A., Khodagholi, F., Jorjani, M., Aromatase inhibition exacerbates pain and reactive gliosis in the dorsal horn of the spinal cord of female rats caused by spinothalamic tract injury. Endocrinology 155 (2014), 4341–4355.
116. Ghoumari, A.M., Baulieu, E.E., Schumacher, M., Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 135 (2005), 47–58.
117. Ghoumari, A.M., Ibanez, C., El-Etr, M., Leclerc, P., Eychenne, B., O'Malley, B.W., Baulieu, E.E., Schumacher, M., Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86 (2003), 848–859.
118. Giatti, S., Boraso, M., Melcangi, R., Viviani, B., Neuroactive steroids, their metabolites and neuroinflammation. J. Mol. Endocrinol. 49 (2012), R125–R134.
119. Giatti, S., Caruso, D., Boraso, M., Abbiati, F., Ballarini, E., Calabrese, D., Pesaresi, M., Rigolio, R., Santos-Galindo, M., Viviani, B., Cavaletti, G., Garcia-Segura, L.M., Melcangi, R.C., Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis. J. Neuroendocrinol. 24 (2012), 851–861.
120. Giatti, S., D'Intino, G., Maschi, O., Pesaresi, M., Garcia-Segura, L.M., Calza, L., Caruso, D., Melcangi, R.C., Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem. Int. 56 (2010), 118–127.
121. Giatti, S., Rigolio, R., Romano, S., Mitro, N., Viviani, B., Cavaletti, G., Caruso, D., Garcia-Segura, L.M., Melcangi, R.C., Dihydrotestosterone as a protective agent in chronic experimental autoimmune encephalomyelitis. Neuroendocrinology 101 (2015), 296–308.
122. Gibson, C.L., Gray, L.J., Bath, P.M., Murphy, S.P., Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131 (2008), 318–328.
123. Giraud, S.N., Caron, C.M., Pham-Dinh, D., Kitabgi, P., Nicot, A.B., Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 8416–8421.
124. Gispen, W.H., Biessels, G.J., Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000), 542–549.
125. Gleicher, N., Barad, D.H., Gender as risk factor for autoimmune diseases. J. Autoimmun. 28 (2007), 1–6.
126. Goldstein, J.M., Sex, hormones and affective arousal circuitry dysfunction in schizophrenia. Horm. Behav. 50 (2006), 612–622.
127. Goldstein, J.M., Link, B.G., Gender and the expression of schizophrenia. J. Psychiatr. Res. 22 (1988), 141–155.
128. Goldstein, J.M., Seidman, L.J., Goodman, J.M., Koren, D., Lee, H., Weintraub, S., Tsuang, M.T., Are there sex differences in neuropsychological functions among patients with schizophrenia?. Am. J. Psychiatry 155 (1998), 1358–1364.
129. Goldstein, J.M., Seidman, L.J., Makris, N., Ahern, T., O'Brien, L.M., Caviness, V.S. Jr., Kennedy, D.N., Faraone, S.V., Tsuang, M.T., Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol. Psychiatry 61 (2007), 935–945.
130. Goldstein, J.M., Seidman, L.J., O'Brien, L.M., Horton, N.J., Kennedy, D.N., Makris, N., Caviness, V.S. Jr., Faraone, S.V., Tsuang, M.T., Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch. Gen. Psychiatry 59 (2002), 154–164.
131. Gonzalez Deniselle, M.C., Lopez-Costa, J.J., Saavedra, J.P., Pietranera, L., Gonzalez, S.L., Garay, L., Guennoun, R., Schumacher, M., De Nicola, A.F., Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11 (2002), 457–468.
132. Groswasser, Z., Cohen, M., Keren, O., Female TBI patients recover better than males. Brain Inj. 12 (1998), 805–808.
133. Gudemez, E., Ozer, K., Cunningham, B., Siemionow, K., Browne, E., Siemionow, M., Dehydroepiandrosterone as an enhancer of functional recovery following crush injury to rat sciatic nerve. Microsurgery 22 (2002), 234–241.
134. Guennoun, R., Benmessahel, Y., Delespierre, B., Gouezou, M., Rajkowski, K.M., Baulieu, E.E., Schumacher, M., Progesterone stimulates Krox-20 gene expression in Schwann cells. Brain Res. Mol. Brain Res. 90 (2001), 75–82.
135. Guerra-Araiza, C., Amorim, M.A., Camacho-Arroyo, I., Garcia-Segura, L.M., Effects of progesterone and its reduced metabolites, dihydroprogesterone and tetrahydroprogesterone, on the expression and phosphorylation of glycogen synthase kinase-3 and the microtubule-associated protein tau in the rat cerebellum. Dev. Neurobiol. 67 (2007), 510–520.
136. Gur, R.E., Kohler, C., Turetsky, B.I., Siegel, S.J., Kanes, S.J., Bilker, W.B., Brennan, A.R., Gur, R.C., A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol. Psychiatry 55 (2004), 512–517.
137. Haaxma, C.A., Bloem, B.R., Borm, G.F., Oyen, W.J., Leenders, K.L., Eshuis, S., Booij, J., Dluzen, D.E., Horstink, M.W., Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007), 819–824.
138. Hadj-Sahraoui, N., Frederic, F., Delhaye-Bouchaud, N., Mariani, J., Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse. J. Neurogenet. 11 (1996), 45–58.
139. Hafner, H., Gender differences in schizophrenia. Psychoneuroendocrinology 28:Suppl. 2 (2003), 17–54.
140. Halbreich, U., Kahn, L.S., Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28:Suppl. 2 (2003), 1–16.
141. Hall, E.D., Pazara, K.E., Linseman, K.L., Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11 (1991), 292–298.
142. Hammond, J., Le, Q., Goodyer, C., Gelfand, M., Trifiro, M., LeBlanc, A., Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77 (2001), 1319–1326.
143. Hankin, B.L., Abramson, L.Y., Development of gender differences in depression: description and possible explanations. Ann. Med. 31 (1999), 372–379.
144. Hawkins, S.A., McDonnell, G.V., Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J. Neurol. Neurosurg. Psychiatry 67 (1999), 148–152.
145. He, J., Evans, C.O., Hoffman, S.W., Oyesiku, N.M., Stein, D.G., Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp. Neurol. 189 (2004), 404–412.
146. Holroyd-Leduc, J.M., Kapral, M.K., Austin, P.C., Tu, J.V., Sex differences and similarities in the management and outcome of stroke patients. Stroke 31 (2000), 1833–1837.
147. Homann, C.N., Quehenberger, F., Petrovic, K., Hartung, H.P., Ruzicka, E., Homann, B., Suppan, K., Wenzel, K., Ivanic, G., Ott, E., Influence of age, gender, education and dexterity on upper limb motor performance in Parkinsonian patients and healthy controls. J. Neural Transm. 110 (2003), 885–897.
148. Huppenbauer, C.B., Tanzer, L., DonCarlos, L.L., Jones, K.J., Gonadal steroid attenuation of developing hamster facial motoneuron loss by axotomy: equal efficacy of testosterone, dihydrotestosterone, and 17-beta estradiol. J. Neurosci. 25 (2005), 4004–4013.
149. Ibanez, C., Shields, S.A., El-Etr, M., Leonelli, E., Magnaghi, V., Li, W.W., Sim, F.J., Baulieu, E.E., Melcangi, R.C., Schumacher, M., Franklin, R.J., Steroids and the reversal of age-associated changes in myelination and remyelination. Prog. Neurobiol. 71 (2003), 49–56.
150. Ishihara, Y., Fujitani, N., Kawami, T., Adachi, C., Ishida, A., Yamazaki, T., Suppressive effects of 17beta-estradiol on tributyltin-induced neuronal injury via Akt activation and subsequent attenuation of oxidative stress. Life Sci. 99 (2014), 24–30.
151. Ishrat, T., Sayeed, I., Atif, F., Hua, F., Stein, D.G.C.P., Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 226 (2010), 183–190.
152. Islamov, R.R., Hendricks, W.A., Jones, R.J., Lyall, G.J., Spanier, N.S., Murashov, A.K., 17Beta-estradiol stimulates regeneration of sciatic nerve in female mice. Brain Res. 943 (2002), 283–286.
153. Jackson, G.L., Kuehl, D., Rhim, T.J., Testosterone inhibits gonadotropin-releasing hormone pulse frequency in the male sheep. Biol. Reprod. 45 (1991), 188–194.
154. Jacobson, A.M., Samson, J.A., Weinger, K., Ryan, C.M., Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?. Int. Rev. Neurobiol. 51 (2002), 455–479.
155. Jacobson, D.L., Gange, S.J., Rose, N.R., Graham, N.M., Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84 (1997), 223–243.
156. Jiang, C., Cui, K., Wang, J., He, Y., Microglia and cyclooxygenase-2: possible therapeutic targets of progesterone for stroke. Int. Immunopharmacol. 11 (2011), 1925–1931.
157. Jo, D.H., Abdallah, M.A., Young, J., Baulieu, E.E., Robel, P., Pregnenolone, dehydroepiandrosterone, and their sulfate and fatty acid esters in the rat brain. Steroids 54 (1989), 287–297.
158. Jones, K.J., Brown, T.J., Damaser, M., Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons. Brain Res. Brain Res. Rev. 37 (2001), 372–382.
159. Joseph, E.K., Levine, J.D., Sexual dimorphism in the contribution of protein kinase C isoforms to nociception in the streptozotocin diabetic rat. Neuroscience 120 (2003), 907–913.
160. Jung-Testas, I., Schumacher, M., Robel, P., Baulieu, E.E., The neurosteroid progesterone increases the expression of myelin proteins (MBP and CNPase) in rat oligodendrocytes in primary culture. Cell. Mol. Neurobiol. 16 (1996), 439–443.
161. Kapral, M.K., Fang, J., Hill, M.D., Silver, F., Richards, J., Jaigobin, C., Cheung, A.M., Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 36 (2005), 809–814.
162. Kaye, W., Neurobiology of anorexia and bulimia nervosa. Physiol. Behav. 94 (2008), 121–135.
163. Khasnavis, S., Ghosh, A., Roy, A., Pahan, K., Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase. J. Biol. Chem. 288 (2013), 20843–20855.
164. Kim, H.J., Ha, M., Park, C.H., Park, S.J., Youn, S.M., Kang, S.S., Cho, G.J., Choi, W.S., StAR and steroidogenic enzyme transcriptional regulation in the rat brain: effects of acute alcohol administration. Brain Res. Mol. Brain Res. 115 (2003), 39–49.
165. Kimura, K., Minematsu, K., Kazui, S., Yamaguchi, T., Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc. Dis. 19 (2005), 171–178.
166. Kiziltan, M.E., Gunduz, A., Kiziltan, G., Akalin, M.A., Uzun, N., Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. J. Neurol. Sci. 258 (2007), 75–79.
167. Kodl, C.T., Seaquist, E.R., Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 29 (2008), 494–511.
168. Koenig, H.L., Schumacher, M., Ferzaz, B., Thi, A.N., Ressouches, A., Guennoun, R., Jung-Testas, I., Robel, P., Akwa, Y., Baulieu, E.E., Progesterone synthesis and myelin formation by Schwann cells. Science 268 (1995), 1500–1503.
169. Kovacic, U., Sketelj, J., Bajrovic, F.F., Sex-related difference in collateral sprouting of nociceptive axons after peripheral nerve injury in the rat. Exp. Neurol. 184 (2003), 479–488.
170. Kovacic, U., Zele, T., Osredkar, J., Sketelj, J., Bajrovic, F.F., Sex-related differences in the regeneration of sensory axons and recovery of nociception after peripheral nerve crush in the rat. Exp. Neurol. 189 (2004), 94–104.
171. Kramar, E.A., Babayan, A.H., Gall, C.M., Lynch, G., Estrogen promotes learning-related plasticity by modifying the synaptic cytoskeleton. Neuroscience 239 (2013), 3–16.
172. Kraszpulski, M., Soininen, H., Helisalmi, S., Alafuzoff, I., The load and distribution of beta-amyloid in brain tissue of patients with Alzheimer's disease. Acta Neurol. Scand. 103 (2001), 88–92.
173. Kraus, J.F., Peek-Asa, C., McArthur, D., The independent effect of gender on outcomes following traumatic brain injury: a preliminary investigation. Neurosurg. Focus, 8, 2000, e5.
174. Kumar, P., Khan, A., Deshmukh, R., Lal Sharma, P., Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats. Eur. J. Pharmacol. 723 (2014), 38–45.
175. Kumsar, S., Kumsar, N.A., Saglam, H.S., Kose, O., Budak, S., Adsan, O., Testosterone levels and sexual function disorders in depressive female patients: effects of antidepressant treatment. J. Sex. Med. 11 (2014), 529–535.
176. Kurth, F., Luders, E., Sicotte, N.L., Gaser, C., Giesser, B.S., Swerdloff, R.S., Montag, M.J., Voskuhl, R.R., Mackenzie-Graham, A., Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin. 4 (2014), 454–460.
177. Labombarda, F., Gonzalez, S., Gonzalez Deniselle, M.C., Garay, L., Guennoun, R., Schumacher, M., De Nicola, A.F., Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord. J. Neurotrauma 23 (2006), 181–192.
178. Labombarda, F., Gonzalez, S.L., Lima, A., Roig, P., Guennoun, R., Schumacher, M., de Nicola, A.F., Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57 (2009), 884–897.
179. Labombarda, F., Pianos, A., Liere, P., Eychenne, B., Gonzalez, S., Cambourg, A., De Nicola, A.F., Schumacher, M., Guennoun, R., Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology 147 (2006), 1847–1859.
180. Lagunas, N., Calmarza-Font, I., Diz-Chaves, Y., Garcia-Segura, L.M., Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Horm. Behav. 58 (2010), 786–791.
181. Lavaque, E., Mayen, A., Azcoitia, I., Tena-Sempere, M., Garcia-Segura, L.M., Sex differences, developmental changes, response to injury and cAMP regulation of the mRNA levels of steroidogenic acute regulatory protein, cytochrome p450scc, and aromatase in the olivocerebellar system. J. Neurobiol. 66 (2006), 308–318.
182. Lavaque, E., Sierra, A., Azcoitia, I., Garcia-Segura, L.M., Steroidogenic acute regulatory protein in the brain. Neuroscience 138 (2006), 741–747.
183. Leonelli, E., Bianchi, R., Cavaletti, G., Caruso, D., Crippa, D., Garcia-Segura, L.M., Lauria, G., Magnaghi, V., Roglio, I., Melcangi, R.C., Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144 (2007), 1293–1304.
184. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M., McGowan, E., Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293 (2001), 1487–1491.
185. Liu, A., Margaill, I., Zhang, S., Labombarda, F., Coqueran, B., Delespierre, B., Liere, P., Marchand-Leroux, C., O'Malley, B.W., Lydon, J.P., De Nicola, A.F., Sitruk-Ware, R., Mattern, C., Plotkine, M., Schumacher, M., Guennoun, R., Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology 153 (2012), 3747–3757.
186. Liu, H., Harrell, L.E., Shenvi, S., Hagen, T., Liu, R.M., Gender differences in glutathione metabolism in Alzheimer's disease. J. Neurosci. Res. 79 (2005), 861–867.
187. Liu, M., Hurn, P.D., Roselli, C.E., Alkayed, N.J., Role of P450 aromatase in sex-specific astrocytic cell death. J. Cereb. Blood Flow Metab. 27 (2007), 135–141.
188. Liu, S.B., Han, J., Zhang, N., Tian, Z., Li, X.B., Zhao, M.G., Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor. Clin. Exp. Pharmacol. Physiol. 38 (2011), 577–585.
189. Lloret, A., Badia, M.C., Mora, N.J., Ortega, A., Pallardo, F.V., Alonso, M.D., Atamna, H., Vina, J., Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease. Free Radical Biol. Med. 44 (2008), 2019–2025.
190. Lopez Rodriguez, A.B., Mateos Vicente, B., Romero-Zerbo, S.Y., Rodriguez-Rodriguez, N., Bellini, M.J., Rodriguez de Fonseca, F., Bermudez-Silva, F.J., Azcoitia, I., Garcia-Segura, L.M., Viveros, M.P., Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors. Cereb. Cortex 21 (2011), 2046–2055.
191. Lopez-Rodriguez, A.B., Acaz-Fonseca, E., Giatti, S., Caruso, D., Viveros, M.P., Melcangi, R.C., Garcia-Segura, L.M., Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice. Psychoneuroendocrinology 56 (2015), 1–11.
192. Luchetti, S., Bossers, K., Frajese, G.V., Swaab, D.F., Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease. Brain Pathol. 20 (2010), 945–951.
193. Luchetti, S., Bossers, K., Van de Bilt, S., Agrapart, V., Morales, R.R., Frajese, G.V., Swaab, D.F., Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease. Neurobiol. Aging 32 (2011), 1964–1976.
194. Luchetti, S., Huitinga, I., Swaab, D.F., Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 191 (2011), 6–21.
195. Luchetti, S., van Eden, C.G., Schuurman, K., van Strien, M.E., Swaab, D.F., Huitinga, I., Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions. J. Neuropathol. Exp. Neurol. 73 (2014), 123–135.
196. Luquin, S., Naftolin, F., Garcia-Segura, L.M., Natural fluctuation and gonadal hormone regulation of astrocyte immunoreactivity in dentate gyrus. J. Neurobiol. 24 (1993), 913–924.
197. Magnaghi, V., Ballabio, M., Gonzalez, L.C., Leonelli, E., Motta, M., Melcangi, R.C., The synthesis of glycoprotein Po and peripheral myelin protein 22 in sciatic nerve of male rats is modulated by testosterone metabolites. Brain Res. Mol. Brain Res. 126 (2004), 67–73.
198. Magnaghi, V., Ballabio, M., Roglio, I., Melcangi, R.C., Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells. J. Mol. Neurosci. 31 (2007), 149–157.
199. Magnaghi, V., Cavarretta, I., Zucchi, I., Susani, L., Rupprecht, R., Hermann, B., Martini, L., Melcangi, R.C., Po gene expression is modulated by androgens in the sciatic nerve of adult male rats. Brain Res. Mol. Brain Res. 70 (1999), 36–44.
200. Magnaghi, V., Veiga, S., Ballabio, M., Gonzalez, L.C., Garcia-Segura, L.M., Melcangi, R.C., Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells. J. Peripher. Nerv. Syst. 11 (2006), 111–118.
201. Mannix, R., Berglass, J., Berkner, J., Moleus, P., Qiu, J., Jantzie, L.L., Meehan, W.P. 3rd, Stanley, R.M., Robinson, S., Sex differences in the effect of progesterone after controlled cortical impact in adolescent mice: a preliminary study. J. Neurosurg. 121 (2014), 1337–1341.
202. Manwani, B., Bentivegna, K., Benashski, S.E., Venna, V.R., Xu, Y., Arnold, A.P., McCullough, L.D., Sex differences in ischemic stroke sensitivity are influenced by gonadal hormones, not by sex chromosome complement. J. Cereb. Blood Flow Metab. 35 (2015), 221–229.
203. Manwani, B., Liu, F., Scranton, V., Hammond, M.D., Sansing, L.H., McCullough, L.D., Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp. Neurol. 249 (2013), 120–131.
204. Marcus, S.M., Kerber, K.B., Rush, A.J., Wisniewski, S.R., Nierenberg, A., Balasubramani, G.K., Ritz, L., Kornstein, S., Young, E.A., Trivedi, M.H., Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr. Psychiatry 49 (2008), 238–246.
205. Markianos, M., Panas, M., Kalfakis, N., Vassilopoulos, D., Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Ann. Neurol. 57 (2005), 520–525.
206. Martinelli, P., Contin, M., Scaglione, C., Riva, R., Albani, F., Baruzzi, A., Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?. Neurol. Sci. 24 (2003), 192–193.
207. Martinez-Cerdeno, V., Noctor, S.C., Kriegstein, A.R., Estradiol stimulates progenitor cell division in the ventricular and subventricular zones of the embryonic neocortex. Eur. J. Neurosci. 24 (2006), 3475–3488.
208. Marx, C.E., Bradford, D.W., Hamer, R.M., Naylor, J.C., Allen, T.B., Lieberman, J.A., Strauss, J.L., Kilts, J.D., Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence. Neuroscience 191 (2011), 78–90.
209. Marx, C.E., Keefe, R.S., Buchanan, R.W., Hamer, R.M., Kilts, J.D., Bradford, D.W., Strauss, J.L., Naylor, J.C., Payne, V.M., Lieberman, J.A., Savitz, A.J., Leimone, L.A., Dunn, L., Porcu, P., Morrow, A.L., Shampine, L.J., Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology 34 (2009), 1885–1903.
210. Marx, C.E., Trost, W.T., Shampine, L.J., Stevens, R.D., Hulette, C.M., Steffens, D.C., Ervin, J.F., Butterfield, M.I., Blazer, D.G., Massing, M.W., Lieberman, J.A., The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. Biol. Psychiatry 60 (2006), 1287–1294.
211. Matarese, G., Sanna, V., Di Giacomo, A., Lord, G.M., Howard, J.K., Bloom, S.R., Lechler, R.I., Fontana, S., Zappacosta, S., Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur. J. Immunol. 31 (2001), 1324–1332.
212. McCall, A.L., Diabetes mellitus and the central nervous system. Int. Rev. Neurobiol. 51 (2002), 415–453.
213. McCarthy, M.M., Schwarz, J.M., Wright, C.L., Dean, S.L., Mechanisms mediating oestradiol modulation of the developing brain. J. Neuroendocrinol. 20 (2008), 777–783.
214. McCarthy, M.M., Todd, B.J., Amateau, S.K., Estradiol modulation of astrocytes and the establishment of sex differences in the brain. Ann. N.Y. Acad. Sci. 1007 (2003), 283–297.
215. McEwen, B.S., Woolley, C.S., Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp. Gerontol. 29 (1994), 431–436.
216. McHenry, J., Carrier, N., Hull, E., Kabbaj, M., Sex differences in anxiety and depression: role of testosterone. Front. Neuroendocrinol. 35 (2014), 42–57.
217. McIntyre, R.S., Mancini, D., Eisfeld, B.S., Soczynska, J.K., Grupp, L., Konarski, J.Z., Kennedy, S.H., Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology 31 (2006), 1029–1035.
218. Meffre, D., Pianos, A., Liere, P., Eychenne, B., Cambourg, A., Schumacher, M., Stein, D.G., Guennoun, R., Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148 (2007), 2505–2517.
219. Melcangi, R.C., Azcoitia, I., Ballabio, M., Cavarretta, I., Gonzalez, L.C., Leonelli, E., Magnaghi, V., Veiga, S., Garcia-Segura, L.M., Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves. Prog. Neurobiol. 71 (2003), 57–66.
220. Melcangi, R.C., Caruso, D., Levandis, G., Abbiati, F., Armentero, M.T., Blandini, F., Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease. J. Mol. Neurosci. 46 (2012), 177–183.
221. Melcangi, R.C., Cavarretta, I.T., Ballabio, M., Leonelli, E., Schenone, A., Azcoitia, I., Miguel Garcia-Segura, L., Magnaghi, V., Peripheral nerves: a target for the action of neuroactive steroids. Brain Res. Brain Res. Rev. 48 (2005), 328–338.
222. Melcangi, R.C., Garcia-Segura, L.M., Mensah-Nyagan, A.G., Neuroactive steroids: state of the art and new perspectives. Cell. Mol. Life Sci. 65 (2008), 777–797.
223. Melcangi, R.C., Magnaghi, V., Cavarretta, I., Martini, L., Piva, F., Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 85 (1998), 569–578.
224. Melcangi, R.C., Magnaghi, V., Cavarretta, I., Zucchi, I., Bovolin, P., D'Urso, D., Martini, L., Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J. Neurosci. Res. 56 (1999), 349–357.
225. Melcangi, R.C., Magnaghi, V., Galbiati, M., Ghelarducci, B., Sebastiani, L., Martini, L., The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?. J. Neurocytol. 29 (2000), 327–339.
226. Melcangi, R.C., Magnaghi, V., Martini, L., Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones. Prog. Neurobiol. 60 (2000), 291–308.
227. Mensah-Nyagan, A.G., Meyer, L., Schaeffer, V., Kibaly, C., Patte-Mensah, C., Evidence for a key role of steroids in the modulation of pain. Psychoneuroendocrinology 34:Suppl. 1 (2009), S169–S177.
228. Mercier, G., Turque, N., Schumacher, M., Early activation of transcription factor expression in Schwann cells by progesterone. Brain Res. Mol. Brain Res. 97 (2001), 137–148.
229. Meyer, L., Patte-Mensah, C., Taleb, O., Mensah-Nyagan, A.G., Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy. Cell. Mol. Life Sci. 67 (2010), 3017–3034.
230. Meyer, L., Patte-Mensah, C., Taleb, O., Mensah-Nyagan, A.G., Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence. Pain 152 (2011), 170–181.
231. Micevych, P., Sinchak, K., Synthesis and function of hypothalamic neuroprogesterone in reproduction. Endocrinology 149 (2008), 2739–2742.
232. Mitro, N., Cermenati, G., Brioschi, E., Abbiati, F., Audano, M., Giatti, S., Crestani, M., De Fabiani, E., Azcoitia, I., Garcia-Segura, L.M., Caruso, D., Melcangi, R.C., Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy. J. Steroid Biochem. Mol. Biol. 143 (2014), 115–121.
233. Moldovan, I.R., Cotleur, A.C., Zamor, N., Butler, R.S., Pelfrey, C.M., Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens. J. Neuroimmunol. 193 (2008), 161–169.
234. Morales, L.B., Loo, K.K., Liu, H.B., Peterson, C., Tiwari-Woodruff, S., Voskuhl, R.R., Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci. 26 (2006), 6823–6833.
235. Moriarty, P.J., Lieber, D., Bennett, A., White, L., Parrella, M., Harvey, P.D., Davis, K.L., Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr. Bull. 27 (2001), 103–113.
236. Mosquera, L., Colon, J.M., Santiago, J.M., Torrado, A.I., Melendez, M., Segarra, A.C., Rodriguez-Orengo, J.F., Miranda, J.D., Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha. Brain Res. 1561 (2014), 11–22.
237. Mottron, L., Duret, P., Mueller, S., Moore, R.D., Forgeot d'Arc, B., Jacquemont, S., Xiong, L., Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism. Mol. Autism, 6, 2015, 33.
238. Murphy, D.D., Segal, M., Progesterone prevents estradiol-induced dendritic spine formation in cultured hippocampal neurons. Neuroendocrinology 72 (2000), 133–143.
239. Murray, H.E., Pillai, A.V., McArthur, S.R., Razvi, N., Datla, K.P., Dexter, D.T., Gillies, G.E., Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Neuroscience 116 (2003), 213–222.
240. Ng, I., Lee, K.K., Lim, J.H., Wong, H.B., Yan, X.Y., Investigating gender differences in outcome following severe traumatic brain injury in a predominantly Asian population. Br. J. Neurosurg. 20 (2006), 73–78.
241. Nguyen, T.V., Jayaraman, A., Quaglino, A., Pike, C.J., Androgens selectively protect against apoptosis in hippocampal neurones. J. Neuroendocrinol. 22 (2010), 1013–1022.
242. Niemeier, J.P., Marwitz, J.H., Lesher, K., Walker, W.C., Bushnik, T., Gender differences in executive functions following traumatic brain injury. Neuropsychol. Rehabil. 17 (2007), 293–313.
243. Niewada, M., Kobayashi, A., Sandercock, P.A., Kaminski, B., Czlonkowska, A., Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 24 (2005), 123–128.
244. Nitkowska, M., Tomasiuk, R., Czyzyk, M., Friedman, A., Prolactin and sex hormones levels in males with Parkinson's disease. Acta Neurol. Scand. 131 (2015), 411–416.
245. Noonan, C.W., Kathman, S.J., White, M.C., Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 58 (2002), 136–138.
246. Noorbakhsh, F., Ellestad, K.K., Maingat, F., Warren, K.G., Han, M.H., Steinman, L., Baker, G.B., Power, C., Impaired neurosteroid synthesis in multiple sclerosis. Brain 134 (2011), 2703–2721.
247. Ooishi, Y., Kawato, S., Hojo, Y., Hatanaka, Y., Higo, S., Murakami, G., Komatsuzaki, Y., Ogiue-Ikeda, M., Kimoto, T., Mukai, H., Modulation of synaptic plasticity in the hippocampus by hippocampus-derived estrogen and androgen. J. Steroid Biochem. Mol. Biol. 131 (2012), 37–51.
248. Orton, S.M., Herrera, B.M., Yee, I.M., Valdar, W., Ramagopalan, S.V., Sadovnick, A.D., Ebers, G.C., Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5 (2006), 932–936.
249. Osborne, D.M., Edinger, K., Frye, C.A., Chronic administration of androgens with actions at estrogen receptor beta have anti-anxiety and cognitive-enhancing effects in male rats. Age (Dordr.) 31 (2009), 119–126.
250. Ozacmak, V.H., Sayan, H., The effects of 17beta estradiol, 17alpha estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia. Physiol. Res. 58 (2009), 909–912.
251. Padua, L., Aprile, I., Cavallaro, T., Commodari, I., La Torre, G., Pareyson, D., Quattrone, A., Rizzuto, N., Vita, G., Tonali, P., Schenone, A., Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Neurol. Sci. 27 (2006), 417–423.
252. Palaszynski, K.M., Loo, K.K., Ashouri, J.F., Liu, H.B., Voskuhl, R.R., Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 146 (2004), 144–152.
253. Palmen, S.J., van Engeland, H., Hof, P.R., Schmitz, C., Neuropathological findings in autism. Brain 127 (2004), 2572–2583.
254. Pariante, C.M., Vassilopoulou, K., Velakoulis, D., Phillips, L., Soulsby, B., Wood, S.J., Brewer, W., Smith, D.J., Dazzan, P., Yung, A.R., Zervas, I.M., Christodoulou, G.N., Murray, R., McGorry, P.D., Pantelis, C., Pituitary volume in psychosis. Br. J. Psychiatry 185 (2004), 5–10.
255. Parmenter, B.A., Denney, D.R., Lynch, S.G., Middleton, L.S., Harlan, L.M., Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. Mult. Scler. 13 (2007), 25–32.
256. Patte-Mensah, C., Meyer, L., Taleb, O., Mensah-Nyagan, A.G., Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain. Prog. Neurobiol. 113 (2014), 70–78.
257. Paul, S.M., Purdy, R.H., Neuroactive steroids. FASEB J. 6 (1992), 2311–2322.
258. Pekmezovic, T., Svetel, M., Maric, J., Dujmovic-Basuroski, I., Dragasevic, N., Keckarevic, M., Romac, S., Kostic, V.S., Survival of Huntington's disease patients in Serbia: longer survival in female patients. Eur. J. Epidemiol. 22 (2007), 523–526.
259. Pelfrey, C.M., Cotleur, A.C., Lee, J.C., Rudick, R.A., Sex differences in cytokine responses to myelin peptides in multiple sclerosis. J. Neuroimmunol. 130 (2002), 211–223.
260. Perez-Alvarez, M.J., Maza Mdel, C., Anton, M., Ordonez, L., Wandosell, F., Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. J. Neuroinflamm., 9, 2012, 157.
261. Pesaresi, M., Giatti, S., Calabrese, D., Maschi, O., Caruso, D., Melcangi, R.C., Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats. J. Mol. Neurosci. 42 (2010), 135–139.
262. Pesaresi, M., Giatti, S., Cavaletti, G., Abbiati, F., Calabrese, D., Bianchi, R., Caruso, D., Garcia-Segura, L.M., Melcangi, R.C., Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: a correlation with the levels of neuroactive steroids in the sciatic nerve. Exp. Neurol. 228 (2011), 215–221.
263. Pesaresi, M., Giatti, S., Cavaletti, G., Abbiati, F., Calabrese, D., Lombardi, R., Bianchi, R., Lauria, G., Caruso, D., Garcia-Segura, L.M., Melcangi, R.C., Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy. Neuroscience 199 (2011), 401–409.
264. Pesaresi, M., Maschi, O., Giatti, S., Garcia-Segura, L.M., Caruso, D., Melcangi, R.C., Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm. Behav. 57 (2010), 46–55.
265. Peterson, B.L., Won, S., Geddes, R.I., Sayeed, I., Stein, D.G., Sex-related differences in effects of progesterone following neonatal hypoxic brain injury. Behav. Brain Res. 286 (2015), 152–165.
266. Pettus, E.H., Wright, D.W., Stein, D.G., Hoffman, S.W., Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 1049 (2005), 112–119.
267. Pike, C.J., Carroll, J.C., Rosario, E.R., Barron, A.M., Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 30 (2009), 239–258.
268. Platania, P., Seminara, G., Aronica, E., Troost, D., Vincenza Catania, M., Angela Sortino, M., 17beta-estradiol rescues spinal motoneurons from AMPA-induced toxicity: a role for glial cells. Neurobiol. Dis. 20 (2005), 461–470.
269. Pozzilli, C., Tomassini, V., Marinelli, F., Paolillo, A., Gasperini, C., Bastianello, S., ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur. J. Neurol. 10 (2003), 95–97.
270. Quillinan, N., Deng, G., Grewal, H., Herson, P.S., Androgens and stroke: good, bad or indifferent?. Exp. Neurol. 259 (2014), 10–15.
271. Ramsden, M., Shin, T.M., Pike, C.J., Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience 122 (2003), 573–578.
272. Rao, M.L., Kolsch, H., Effects of estrogen on brain development and neuroprotection—implications for negative symptoms in schizophrenia. Psychoneuroendocrinology 28:Suppl. 2 (2003), 83–96.
273. Ratcliff, J.J., Greenspan, A.I., Goldstein, F.C., Stringer, A.Y., Bushnik, T., Hammond, F.M., Novack, T.A., Whyte, J., Wright, D.W., Gender and traumatic brain injury: do the sexes fare differently?. Brain Inj. 21 (2007), 1023–1030.
274. 25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005), 5591–5595.
275. Reeves, M.J., Bushnell, C.D., Howard, G., Gargano, J.W., Duncan, P.W., Lynch, G., Khatiwoda, A., Lisabeth, L., Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 7 (2008), 915–926.
276. Reite, M., Sheeder, J., Teale, P., Adams, M., Richardson, D., Simon, J., Jones, R.H., Rojas, D.C., Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia. Arch. Gen. Psychiatry 54 (1997), 433–440.
277. Reyna-Neyra, A., Camacho-Arroyo, I., Ferrera, P., Arias, C., Estradiol and progesterone modify microtubule associated protein 2 content in the rat hippocampus. Brain Res. Bull. 58 (2002), 607–612.
278. Riecher-Rossler, A., Hafner, H., Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr. Scand. Suppl.(407), 2000, 58–62.
279. Rodriguez-Perez, A.I., Dominguez-Meijide, A., Lanciego, J.L., Guerra, M.J., Labandeira-Garcia, J.L., Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease. Neurobiol. Dis. 58 (2013), 209–219.
280. Roglio, I., Bianchi, R., Camozzi, F., Carozzi, V., Cervellini, I., Crippa, D., Lauria, G., Cavaletti, G., Melcangi, R.C., Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model. J. Peripher. Nerv. Syst. 14 (2009), 36–44.
281. Roglio, I., Bianchi, R., Giatti, S., Cavaletti, G., Caruso, D., Scurati, S., Crippa, D., Garcia-Segura, L.M., Camozzi, F., Lauria, G., Melcangi, R.C., Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell. Mol. Life Sci. 64 (2007), 1158–1168.
282. Roglio, I., Bianchi, R., Gotti, S., Scurati, S., Giatti, S., Pesaresi, M., Caruso, D., Panzica, G.C., Melcangi, R.C., Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 155 (2008), 673–685.
283. Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., Rupprecht, R., Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 155 (1998), 910–913.
284. Roof, R.L., Hall, E.D., Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 17 (2000), 367–388.
285. Roos, R.A., Vegter-van der Vlis, M., Hermans, J., Elshove, H.M., Moll, A.C., van de Kamp, J.J., Bruyn, G.W., Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. J. Med. Genet. 28 (1991), 515–519.
286. Roquer, J., Campello, A.R., Gomis, M., Sex differences in first-ever acute stroke. Stroke 34 (2003), 1581–1585.
287. Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., Nichol, G., O'Donnell, C.J., Roger, V., Rumsfeld, J., Sorlie, P., Steinberger, J., Thom, T., Wasserthiel-Smoller, S., Hong, Y., Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007), e69–e171.
288. Rosario, E.R., Carroll, J., Pike, C.J., Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res. 1359 (2010), 281–290.
289. Rosario, E.R., Carroll, J.C., Pike, C.J., Evaluation of the effects of testosterone and luteinizing hormone on regulation of beta-amyloid in male 3xTg-AD mice. Brain Res. 1466 (2012), 137–145.
290. Rosario, E.R., Chang, L., Head, E.H., Stanczyk, F.Z., Pike, C.J., Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol. Aging 32 (2011), 604–613.
291. Rupprecht, R., Holsboer, F., Neuropsychopharmacological properties of neuroactive steroids. Steroids 64 (1999), 83–91.
292. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T.C., Fan, J., Akula, N., Groyer, G., Adams, D., Schumacher, M., Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discovery 9 (2010), 971–988.
293. Safarinejad, M.R., Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J. Neuroendocrinol. 20 (2008), 1368–1375.
294. Saijo, K., Collier, J.G., Li, A.C., Katzenellenbogen, J.A., Glass, C.K., An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145 (2011), 584–595.
295. Savettieri, G., Messina, D., Andreoli, V., Bonavita, S., Caltagirone, C., Cittadella, R., Farina, D., Fazio, M.C., Girlanda, P., Le Pira, F., Liguori, M., Lugaresi, A., Nocentini, U., Reggio, A., Salemi, G., Tedeschi, G., Trojano, M., Valentino, P., Quattrone, A., Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J. Neurol. 251 (2004), 1208–1214.
296. Sayeed, I., Guo, Q., Hoffman, S.W., Stein, D.G., Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann. Emerg. Med. 47 (2006), 381–389.
297. Sayeed, I., Wali, B., Stein, D.G., Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor. Neurol. Neurosci. 25 (2007), 151–159.
298. Schaeffer, V., Meyer, L., Patte-Mensah, C., Eckert, A., Mensah-Nyagan, A.G., Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Neurochem. Int. 52 (2008), 948–955.
299. Schaeffer, V., Patte-Mensah, C., Eckert, A., Mensah-Nyagan, A.G., Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J. Neurobiol. 66 (2006), 868–881.
300. Schaeffer, V., Patte-Mensah, C., Eckert, A., Mensah-Nyagan, A.G., Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition. Neuroscience 151 (2008), 758–770.
301. Schneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., Przewlocki, R., Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33 (2008), 728–740.
302. Schule, C., Nothdurfter, C., Rupprecht, R., The role of allopregnanolone in depression and anxiety. Prog. Neurobiol. 113 (2014), 79–87.
303. Schwendimann, R.N., Alekseeva, N., Gender issues in multiple sclerosis. Int. Rev. Neurobiol. 79 (2007), 377–392.
304. Seidman, L.J., Goldstein, J.M., Goodman, J.M., Koren, D., Turner, W.M., Faraone, S.V., Tsuang, M.T., Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability. Biol. Psychiatry 42 (1997), 104–115.
305. Selvamani, A., Williams, M.H., Miranda, R.C., Sohrabji, F., Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin. Sci. (Lond.) 127 (2014), 77–89.
306. Shores, M.M., Sloan, K.L., Matsumoto, A.M., Moceri, V.M., Felker, B., Kivlahan, D.R., Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch. Gen. Psychiatry 61 (2004), 162–167.
307. Sicotte, N.L., Giesser, B.S., Tandon, V., Klutch, R., Steiner, B., Drain, A.E., Shattuck, D.W., Hull, L., Wang, H.J., Elashoff, R.M., Swerdloff, R.S., Voskuhl, R.R., Testosterone treatment in multiple sclerosis: a pilot study. Arch. Neurol. 64 (2007), 683–688.
308. Simonds, V.M., Whiffen, V.E., Are gender differences in depression explained by gender differences in co-morbid anxiety?. J. Affect. Disord. 77 (2003), 197–202.
309. Singh, M., Mechanisms of progesterone-induced neuroprotection. Ann. N.Y. Acad. Sci. 1052 (2005), 145–151.
310. Siriphorn, A., Dunham, K.A., Chompoopong, S., Floyd, C.L., Postinjury administration of 17beta-estradiol induces protection in the gray and white matter with associated functional recovery after cervical spinal cord injury in male rats. J. Comp. Neurol. 520 (2012), 2630–2646.
311. Skinner, D.C., Evans, N.P., Delaleu, B., Goodman, R.L., Bouchard, P., Caraty, A., The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor. Proc. Natl. Acad. Sci. U S A 95 (1998), 10978–10983.
312. Slewa-Younan, S., Green, A.M., Baguley, I.J., Gurka, J.A., Marosszeky, J.E., Sex differences in injury severity and outcome measures after traumatic brain injury. Arch. Phys. Med. Rehabil. 85 (2004), 376–379.
313. Sohrabji, F., Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study. Front. Neuroendocrinol. 36 (2015), 1–14.
314. Spence, R.D., Voskuhl, R.R., Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front. Neuroendocrinol. 33 (2012), 105–115.
315. Stack, C.M., Lim, M.A., Cuasay, K., Stone, M.M., Seibert, K.M., Spivak-Pohis, I., Crawley, J.N., Waschek, J.A., Hill, J.M., Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Exp. Neurol. 211 (2008), 67–84.
316. Steiner, R.A., Bremner, W.J., Clifton, D.K., Regulation of luteinizing hormone pulse frequency and amplitude by testosterone in the adult male rat. Endocrinology 111 (1982), 2055–2061.
317. Szymanski, S., Lieberman, J.A., Alvir, J.M., Mayerhoff, D., Loebel, A., Geisler, S., Chakos, M., Koreen, A., Jody, D., Kane, J., et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am. J. Psychiatry 152 (1995), 698–703.
318. Takahashi, T., Suzuki, M., Kawasaki, Y., Hagino, H., Yamashita, I., Nohara, S., Nakamura, K., Seto, H., Kurachi, M., Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 53 (2003), 593–600.
319. Tanzer, L., Jones, K.J., Neurotherapeutic action of testosterone on hamster facial nerve regeneration: temporal window of effects. Horm. Behav. 45 (2004), 339–344.
320. Taylor, L.C., Puranam, K., Gilmore, W., Ting, J.P., Matsushima, G.K., 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Neurobiol. Dis. 39 (2010), 127–137.
321. Torres-Aleman, I., Rejas, M.T., Pons, S., Garcia-Segura, L.M., Estradiol promotes cell shape changes and glial fibrillary acidic protein redistribution in hypothalamic astrocytes in vitro: a neuronal-mediated effect. Glia 6 (1992), 180–187.
322. Tsutsui, K., Neurosteroid biosynthesis and action during cerebellar development. Cerebellum 11 (2012), 414–415.
323. Tsutsui, K., Ukena, K., Sakamoto, H., Okuyama, S., Haraguchi, S., Biosynthesis, mode of action, and functional significance of neurosteroids in the purkinje cell. Front. Endocrinol. (Lausanne), 2, 2011, 61.
324. Tunez, I., Collado, J.A., Medina, F.J., Pena, J., Del, C.M.M., Jimena, I., Franco, F., Rueda, I., Feijoo, M., Muntane, J., Montilla, P., 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats. Neurochem. Int. 48 (2006), 367–373.
325. Turtzo, L.C., McCullough, L.D., Sex differences in stroke. Cerebrovasc. Dis. 26 (2008), 462–474.
326. Uzunova, V., Sheline, Y., Davis, J.M., Rasmusson, A., Uzunov, D.P., Costa, E., Guidotti, A., Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 3239–3244.
327. Van Den Eeden, S.K., Tanner, C.M., Bernstein, A.L., Fross, R.D., Leimpeter, A., Bloch, D.A., Nelson, L.M., Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 157 (2003), 1015–1022.
328. VanLandingham, J.W., Cekic, M., Cutler, S., Hoffman, S.W., Stein, D.G.C.P., Neurosteroids reduce inflammation after TBI through CD55 induction. Neurosci. Lett. 425 (2007), 94–98.
329. Vedel Kessing, L., Gender differences in patients presenting with a single depressive episode according to ICD-10. Soc. Psychiatry Psychiatr. Epidemiol. 40 (2005), 197–201.
330. Veiga, S., Leonelli, E., Beelke, M., Garcia-Segura, L.M., Melcangi, R.C., Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci. Lett. 402 (2006), 150–153.
331. Velazquez-Zamora, D.A., Garcia-Segura, L.M., Gonzalez-Burgos, I., Effects of selective estrogen receptor modulators on allocentric working memory performance and on dendritic spines in medial prefrontal cortex pyramidal neurons of ovariectomized rats. Horm. Behav. 61 (2012), 512–517.
332. Veliskova, J., The role of estrogens in seizures and epilepsy: the bad guys or the good guys?. Neuroscience 138 (2006), 837–844.
333. Vita, G., Dattola, R., Girlanda, P., Oteri, G., Lo Presti, F., Messina, C., Effects of steroid hormones on muscle reinnervation after nerve crush in rabbit. Exp. Neurol. 80 (1983), 279–287.
334. Volkmar, F.R., Szatmari, P., Sparrow, S.S., Sex differences in pervasive developmental disorders. J. Autism Dev. Disord. 23 (1993), 579–591.
335. Wagner, A.K., Bayir, H., Ren, D., Puccio, A., Zafonte, R.D., Kochanek, P.M., Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J. Neurotrauma 21 (2004), 125–136.
336. Walf, A.A., Frye, C.A., Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiol. Behav. 99 (2010), 169–174.
337. Walf, A.A., Frye, C.A., Gestational or acute restraint in adulthood reduces levels of 5alpha-reduced testosterone metabolites in the hippocampus and produces behavioral inhibition of adult male rats. Front. Cell. Neurosci., 6, 2012, 40.
338. Walf, A.A., Frye, C.A., Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiol. Behav. 99 (2014), 169–174.
339. Walf, A.A., Paris, J.J., Frye, C.A., Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology 34 (2009), 909–916.
340. Wang, J.M., Liu, L., Irwin, R.W., Chen, S., Brinton, R.D., Regenerative potential of allopregnanolone. Brain Res. Rev. 57 (2008), 398–409.
341. Wei, T., Lightman, S.L., The neuroendocrine axis in patients with multiple sclerosis. Brain 120:Pt 6 (1997), 1067–1076.
342. Wirth, M.M., Beyond the HPA axis: progesterone-derived neuroactive steroids in human stress and emotion. Front. Endocrinol. (Lausanne), 2, 2011, 19.
343. Wooten, G.F., Currie, L.J., Bovbjerg, V.E., Lee, J.K., Patrie, J., Are men at greater risk for Parkinson's disease than women?. J. Neurol. Neurosurg. Psychiatry 75 (2004), 637–639.
344. Yang, S.Y., He, X.Y., Isaacs, C., Dobkin, C., Miller, D., Philipp, M., Roles of 17beta-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders. J. Steroid Biochem. Mol. Biol. 143 (2014), 460–472.
345. Yorek, M.A., Coppey, L.J., Gellett, J.S., Davidson, E.P., Bing, X., Lund, D.D., Dillon, J.S., Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am. J. Physiol. Endocrinol. Metab. 283 (2002), E1067–E1075.
346. Yu, W.H., Effect of testosterone on the regeneration of the hypoglossal nerve in rats. Exp. Neurol. 77 (1982), 129–141.
347. Yu, W.H., Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res. 491 (1989), 379–382.
348. Yue, X., Lu, M., Lancaster, T., Cao, P., Honda, S., Staufenbiel, M., Harada, N., Zhong, Z., Shen, Y., Li, R., Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 19198–19203.
349. Zappia, M., Annesi, G., Nicoletti, G., Arabia, G., Annesi, F., Messina, D., Pugliese, P., Spadafora, P., Tarantino, P., Carrideo, S., Civitelli, D., De Marco, E.V., Ciro-Candiano, I.C., Gambardella, A., Quattrone, A., Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch. Neurol. 62 (2005), 601–605.
350. Zhang, Q.G., Raz, L., Wang, R., Han, D., De Sevilla, L., Yang, F., Vadlamudi, R.K., Brann, D.W., Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J. Neurosci. 29 (2009), 13823–13836.
351. Zhang, Q.G., Wang, R., Tang, H., Dong, Y., Chan, A., Sareddy, G.R., Vadlamudi, R.K., Brann, D.W., Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus. Mol. Cell. Endocrinol. 389 (2014), 84–91.
352. Zhang, Y., Champagne, N., Beitel, L.K., Goodyer, C.G., Trifiro, M., LeBlanc, A., Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J. Neurosci. 24 (2004), 5315–5321.
353. Zhu, H., Han, X., Ji, D., Lv, G., Xu, M., Estrogen inhibits lipid peroxidation after hypoxic-ischemic brain damage in neonatal rats. Neural Regen. Res. 7 (2012), 2424–2431.
354. Zorumski, C.F., Paul, S.M., Izumi, Y., Covey, D.F., Mennerick, S., Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci. Biobehav. Rev. 37 (2013), 109–122.
355. Zuloaga, K.L., Swift, S.N., Gonzales, R.J., Wu, T.J., Handa, R.J., The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells. Endocrinology 153 (2012), 5949–5960.
356. Zup, S.L., Edwards, N.S., McCarthy, M.M., Sex- and age-dependent effects of androgens on glutamate-induced cell death and intracellular calcium regulation in the developing hippocampus. Neuroscience 281C (2014), 77–87.